173 related articles for article (PubMed ID: 26929268)
1. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the β-Lactamase Bla
Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
[No Abstract] [Full Text] [Related]
3. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem.
Le Run E; Atze H; Arthur M; Mainardi JL
J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424
[TBL] [Abstract][Full Text] [Related]
4. β-Lactamase inhibition by avibactam in Mycobacterium abscessus.
Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M
J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201
[TBL] [Abstract][Full Text] [Related]
5.
Le Run E; Arthur M; Mainardi JL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
[TBL] [Abstract][Full Text] [Related]
6. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.
Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499
[No Abstract] [Full Text] [Related]
7.
Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
[TBL] [Abstract][Full Text] [Related]
9.
Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
[No Abstract] [Full Text] [Related]
10. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
[TBL] [Abstract][Full Text] [Related]
11. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
[TBL] [Abstract][Full Text] [Related]
12. Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
Negatu DA; Zimmerman MD; Dartois V; Dick T
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0079022. PubMed ID: 36047786
[TBL] [Abstract][Full Text] [Related]
13. In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus.
Sanchez L; Bitar M; Herail Q; Dorchêne D; Hugonnet JE; Arthur M; Mainardi JL
J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38943535
[TBL] [Abstract][Full Text] [Related]
14. Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
Lopeman RC; Harrison J; Rathbone DL; Desai M; Lambert PA; Cox JAG
Sci Rep; 2020 Jan; 10(1):928. PubMed ID: 31988293
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
Raynaud C; Daher W; Roquet-Banères F; Johansen MD; Stec J; Onajole OK; Ordway D; Kozikowski AP; Kremer L
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041716
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.
Lavollay M; Dubée V; Heym B; Herrmann JL; Gaillard JL; Gutmann L; Arthur M; Mainardi JL
Clin Microbiol Infect; 2014 May; 20(5):O297-300. PubMed ID: 24112243
[TBL] [Abstract][Full Text] [Related]
17. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
19. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
Pozuelo Torres M; van Ingen J
Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
[TBL] [Abstract][Full Text] [Related]
20.
Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
